The spectrum of extra-renal involvement secondary to diarrhoeal (D+) haemolytic uraemic syndrome (HUS) includes neurological, gastrointestinal, hepatic, pancreatic and cardiac complications. Among the cardiac complications, myocardial injury has been more commonly reported with HUS. Literature is scarce on HUS-associated pericardial involvement. We report a HUS-induced significant pericardial effusion that resulted in a cardiac tamponade. We also discuss the diagnostic and therapeutic implications of this complication.
Introduction
Among different extra-renal organ manifestations in diarrhoeal (D+) haemolytic uraemic syndrome (HUS), cardiac involvement is an uncommon, but clinically significant complication. Myocardial involvement has been more commonly reported with HUS [1] [2] [3] [4] . We report a significant pericardial effusion, leading to cardiac tamponade, in a child with D+ HUS.
Case report
A previously healthy 2-year-old boy presented with a 4-day history of bloody diarrhoea. At presentation, he was unwell, lethargic, afebrile and hypertensive (blood pressure 133/90 mmHg), with no peripheral oedema. The initial blood investigations revealed white blood cells (WBC) of 10.9 × 10 9 /L, platelet count 263 × 10 9 /L, haemoglobin 147 g/L, blood urea nitrogen (BUN) 7.2 mmol/L and creatinine 36 µmol/L. Urinanalysis showed 1 g/L of protein and also large blood. Initial abdominal ultrasound revealed Within 2 days, BUN and serum creatinine rose to 25 mmol/L and 271 µmol/L, respectively. Due to diureticunresponsive anuria and rapid BUN and creatinine rise, continuous veno-venous haemodiafiltration (CVVHDF) was instituted. Peritoneal dialysis was withheld because of the pancolitis. Later, CVVHDF was switched to daily intermittent haemodialysis. In view of the significantly elevated WBC and CRP, antibiotic coverage was initially administered, although all cultures subsequently remained negative.
Three days after admission, a protocolized creatinine kinase (CK) and troponin-I increased from initial normal levels to 894 U/L (38-174 U/L) and 0.33 µg/L (<0.08 µg/L), respectively. At this point, his ECG was normal, and the echocardiogram (ECHO) showed an ejection fraction (EF) of 82%, with no evidence of pericardial effusion.
On Day 6 of the hospitalization, he became hypotensive and required inotropic support. A chest X-ray showed a left-sided pleural effusion, pulmonary oedema and an enlarged cardiac silhouette. CK and troponin-I levels also further increased to 1646 U/L and 7.83 µg/L, respectively ( Figure 1 ). Within another 9 h, hypotension worsened, and repeat ECHO showed a significant pericardial effusion, a decreased left ventricular function (EF 56%) and paradoxical movement of right atrium suggesting cardiac tamponade. An immediate pericardiocentesis drained 85 mL of fluid. Over the course of next 3 days, an in situ pericardial drain removed 132 mL of fluid, and CK and troponin-I levels began to fall ( Figure 1 and Table 1 ). With improved blood pressure, inotropes were weaned over 3 days, and the pericardial drain was removed after 4 days. The pericardial fluid analysis revealed an exudative profile (protein 39 g/L, glucose 9.6 mmol/L and nucleated cells 0.480 × 10 9 /L, with 94% neutrophils) and grew no organisms. After removal of the pericardial drain, a repeat ECHO showed no residual pericardial effusion and an improved EF of 80%. Troponin-I levels normalized by Day 26 of the hospitalization. The serologies for Epstein-Barr virus, cytomegalovirus, herpes simplex virus type 1 and type 2, human immune deficiency virus, hepatitis B, hepatitis C and enterovirus were negative. Blood culture remained sterile for any viral, bacterial or fungal growth. Antinuclear antibodies (ANA), anti-dsDNA, anti-glomerular basement membrane (GBM) antibodies, pANCA, cANCA and anti-ENA screen (anti-SM, RNP, SSA/RO, SSB/LA, SCL-70, JO-1 antibodies) were negative. Free T3, free T4 and TSH were normal.
Throughout the course, the patient's neurological and pancreatic status remained unaffected. A mild transaminitis during the course subsided unremarkably. After an improvement in his pancolitis, the patient was switched to peritoneal dialysis (PD) on Day 21 of the hospitalization. PD was weaned once his renal functions improved. During the follow-up, further complications ensued. Three months after his initial presentation, the patient required a sigmoid colon resection and an end-to-end anastmosis for an intestinal obstruction. Histopathological findings confirmed a radial stricture with extensive haemorrhagic mucosal infarction, granulation tissue and fibrosis. During this episode, he again required dialytic support in the form of haemodialysis. At 4 months' follow-up, his cystatin C-based glomerular filtration rate was 20/mL/1.73 m 2 , and the urinary microalbumin-to-creatinine ratio was 1402 mg/mmoL. He has been on enalapril 0.35 mg/kg/day and losartan 1.56 mg/kg/day for microalbuminuria and blood pressure control.
Discussion
The reported cardiac complications in HUS have been predominantly in the form of myocardial involvement [3] [4] [5] . The clinical manifestations from myocardial injury can vary from an asymptomatic decrease in ventricular function [2] and mild ECG changes [4] to fulminant heart failure, significant arrhythmias [6] and death [6, 7] . Reports are scarce on pericardial involvement in HUS. Tobias [5] reported a 9-month-old child with an incidental pericardial effusion, followed by spontaneous resolution. In contrast, Birk et al. reported a 6-year-old girl with cardiac tamponade as the terminal event [7] . Although not related to the HUS disease process, Oakes et al. have reported a fatal iatrogenic cardiac tamponade in a HUS patient [8] . In a case series on haematopoietic stem cell transplantation for various malignancies, 10 of 193 children developed HUS and 60% (6 of 10) of the HUS patients developed pericardial effusion [9] .
We examined the findings in our patient to establish aetiology of the pericardial effusion. Early initiation of regular dialysis suggested against a uraemic origin of the effusion.
Imaging did not reveal a major vessel interruption. The culture from the drained pericardial fluid remained sterile. The absence of pericardial effusion on initial echocardiography excluded a pre-existing pericardial pathology. A detailed viral, bacterial, autoimmune and thyroid function screen was also negative. In view of elevated troponin-I levels, a temporal relationship of HUS onset with effusion development, the absence of an alternative aetiology and a recognized potential of cardiac injury from HUS [1] [2] [3] [4] , the pericardial effusion in our patient appears likely to be secondary to HUS.
The mechanism of pericardial effusion in HUS is not well defined. Our case, and also the two HUS patients described by Tobias and Birk et al., had associated myocardial involvement [5, 7] . Traditionally, myocardial injury is believed to be secondary to thrombotic microangiopathy [10, 11] , although a fatal, histologically proven myocarditis has also been reported in a 13-year-old girl [6] . Also, in the patient reported by Birk et al., massive cardiac tamponade had an associated significant myocarditis without any autopsy evidence of microthrombi [7] . With coexisting myocardial involvement, we speculate that pericardial effusion is more likely a reactive response from the adjoining myocardial inflammation. An exudative nature of pericardial fluid in our patient further supports this hypothesis.
The role of troponin-I as a screening tool to detect cardiac injury in HUS can be debated, as the troponin-I level can also increase from concomitant renal failure. In a small case series, Thayu et al. reported normal troponin-I levels in eight HUS children with unaffected cardiac parameters despite coexisting renal failure, whereas one child with cardiac involvement had an elevated troponin-I level [3] . Moreover, Askiti et al. described a temporal relationship of troponin-I rise with significant myocardial injury in HUS [12] . Our patient also demonstrated a troponin-I rise that preceded the cardiac tamponade and subsided after its resolution, despite persistent renal failure during this period.
In summary, our patient highlights the potential of therapeutically significant pericardial effusion in HUS. The role of troponin-I as a screening tool for cardiac injury in HUS needs evaluation.
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